Menopause Hormone Therapy May Boost GLP-1 Drug Benefits​Menopause Hormone Therapy May Boost GLP-1 Drug Benefits 

(MedPage Today) — Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. Among 120 women with overweight or obesity… ​ (MedPage Today) — Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they Read More

Ozempic boom collides with America’s eating habits as restaurants shrink portions​Ozempic boom collides with America’s eating habits as restaurants shrink portions 

Once known for bottomless breadsticks and supersized meals, American chain restaurants are increasingly rethinking their portion sizes. As GLP-1 weight-loss medications like Ozempic, Wegovy and Zepbound go mainstream, restaurants are responding to customers with smaller appetites — and a growing appetite for protein-packed meals. “People on GLP-1s are prioritizing protein because it’s the macronutrient that Read More